The committee has served as a platform to strengthen cooperation as well as promote innovation and further development in the biopharmaceutical industry in China, according to Anna Van Acker, global senior vice president of MSD.

"MSD has actively responded to China's new development strategy and has readily participated in the CIIE by being the largest exhibition area in the pharmaceutical and healthcare sector," said Van Acker. "MSD fully supports the Chinese government's efforts to promote high-level opening-up and high-quality development."

Zhang Guangzheng contributed to this story.